公司資料
Biodexa Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- BDRX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United Kingdom and listed in the U
股票表現
0.68 USD (-6.86%)
收盤價
最後更新: 2026年9月21日
2.61M USD
市值
股價為何變動
截至 2026年9月21日，BDRX 下跌 6.86%，收於 $0.6799。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Biodexa Pharmaceuticals is a specialty pharmaceutical company focused on oncology and rare disease. Its story is built around using focused development programs to address high-unmet-need conditions.
所在地與產業分類
Biodexa is headquartered in the United Kingdom and listed in the U.S. market. It sits in specialty pharma and oncology development.
商業模式特徵
The company depends on clinical progress, capital efficiency, and the ability to maintain a narrow pipeline. Investors usually watch data updates and strategic changes.
生技產業定位
Biodexa occupies a small oncology/rare-disease niche within biotech-adjacent pharma. It is a catalyst-driven story where a limited number of programs dominate the valuation.
未來催化劑
- Biodexa’s catalysts are its oncology and rare-disease programs, plus any strategic update that clarifies the company’s next move. The stock remains highly dependent on clinical proof.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。